PBS Biotech Secures $22M in Later Stage VC Funding
Represented PBS Biotech in its $22M later stage VC financing round. PBS Biotech manufactures
single-use bioreactor systems intended to create homogeneous and scalable mixing conditions for a variety of sensitive cell therapy products and cell culture applications.